Quantcast
Last updated on April 16, 2014 at 5:49 EDT

Latest Hematopoietic stem cell transplantation Stories

2013-11-01 08:26:48

No Better Time to Get Involved and Register as a Lifesaver NEW YORK, Nov. 1, 2013 /PRNewswire/ -- Blood cancer is the second leading cause of all cancer deaths in the United States. To lend greater awareness to a solution to this issue, Delete Blood Cancer DKMS proudly announces that November is Bone Marrow Awareness Month. Blood cancer refers to cancers that affect the blood, bone marrow and lymph nodes. Notably this will be cancer such as leukemia, myeloma and lymphoma. Many patients...

2013-10-31 11:19:00

Remissions last longer, but survival not affected, except in highest risk patients Performing early stem cell transplants in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published in the New England Journal of Medicine. But early transplantation does appear to be beneficial among a small group of patients who are at the very highest risk, the study found. Lead author is Patrick Stiff, MD, director of...

2013-10-31 08:32:19

Management will discuss pivotal trial plans for its drug candidate Iomab(TM)-B and its potential as a new treatment paradigm for certain blood cancers NEW YORK, Oct. 31, 2013 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, will host a general corporate update and Virtual Roadshow to discuss the current plans...

2013-10-30 23:22:19

STEMSOFT Software Inc. (“STEMSOFT”) is pleased to announce that the Center for International Blood & Marrow Transplant Research (CIBMTR®) has certified STEMSOFTconnect: REGISTRY to electronically submit all available forms using the CIBMTR AGNIS system. Vancouver, BC (PRWEB) October 30, 2013 STEMSOFT Software Inc. (“STEMSOFT”) is pleased to announce that the Center for International Blood & Marrow Transplant Research (CIBMTR®) has certified STEMSOFTconnect:...

2013-10-29 04:21:10

STOCKHOLM, Sweden, October 29, 2013 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo(TM), a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration (FDA). The Company is currently preparing for registration trials...

2013-10-28 08:28:31

November 1, 2013 at 2:00 PM EDT PRINCETON, N.J., Oct. 28, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that Christopher J. Schaber, PhD, President and Chief Executive Officer, Oreola Donini, PhD, Vice President of Preclinical Research and Development,...

2013-10-24 12:25:21

Radiation, graft-versus-host disease cited as particularly damaging WASHINGTON, Oct. 24, 2013 /PRNewswire-USNewswire/ -- New research ties preparative procedures and complications associated with blood or bone marrow transplantation (stem cell transplantation, SCT) with diminished sexual health in both men and women who have undergone the lifesaving procedure. Study data, published today in Blood, the Journal of the American Society of Hematology (ASH), confirm chronic...

2013-10-23 23:01:12

Western University of Health Sciences will honor two health care pioneers at its annual A Tribute to Caring (ATC) gala on Saturday, Nov. 9, 2013 at the Disneyland Hotel in Anaheim, Calif. Funds raised each year from A Tribute to Caring provide crucial scholarship support for WesternU students. Pomona, CA (PRWEB) October 23, 2013 Western University of Health Sciences will honor two health care pioneers at its annual A Tribute to Caring (ATC) gala on Saturday, Nov. 9, 2013 at the Disneyland...

2013-10-22 08:34:23

THOUSAND OAKS, Calif., Oct. 22, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has entered into a definitive agreement with F. Hoffmann-La Roche ("Roche") to acquire Roche's rights to filgrastim and pegfilgrastim in approximately 100 markets, effective Jan. 1, 2014. Roche has held the rights to filgrastim and pegfilgrastim under license from Kirin-Amgen, Inc. (a joint venture between Amgen and Kirin Holdings Co. Limited, of Japan) in Eastern Europe, Latin America,...

2013-10-09 11:39:15

New method for improving cord blood transplant success Starting with a discovery in zebrafish in 2007, Harvard Stem Cell Institute (HSCI) researchers have published initial results of a Phase Ib human clinical trial of a therapeutic that has the potential to improve the success of blood stem cell transplantation. This marks the first time, just nine short years after Harvard's major commitment to stem cell biology, that investigators have carried a discovery from the lab bench to the...


Latest Hematopoietic stem cell transplantation Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »